Skip to main content
S 627 113th Congress Senate Health Advanced technology and technological innovations Advisory bodies Drug safety, medical device, and laboratory regulation Health care costs and insurance Immunology and vaccination Insurance industry and regulation Intellectual property Manufacturing Marketing and advertising Medical research Prescription drugs Research administration and funding Research and development User charges and fees

Medical Innovation Prize Fund Act

Introduced: March 20, 2013 Introduced by: Sanders, Bernard Independent · Vermont See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 113th Congress ended
It never became law before the 113th Congress (2013–2014) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 20, 2013
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 20, 2013
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Medical Innovation Prize Fund Act - Denies any person the exclusive right to manufacture, distribute, sell, or use in interstate commerce a drug, a biological product, or a drug or biological product manufacturing process, including the exclusive right to rely on health registration data or the 30-month stay-of-effectiveness period for Orange Book patents. Prescribes remuneration, in the form of prize payments from a Fund for Medical Innovation Prizes, in lieu of such market exclusivity.

Establishes: (1) the Fund for Medical Innovation Prizes; and (2) a Board of Trustees for such Fund, which shall award prize payments for medical innovation and establish independent expert advisory committees.

Directs the Board to award prize payments for medical innovation relating to a drug, a biological product, or a new manufacturing process for a drug or biological product to: (1) the first person to receive market clearance with respect to the drug or biological product; (2) the holder of the patent with respect to a manufacturing process; or (3) persons or communities that as an open source contribution openly shared knowledge, data, materials, and technology on a royalty-free and nondiscriminatory basis.

Requires the Board to establish and periodically modify minimum levels of funding for such awards for priority research and development, including global neglected diseases, orphan diseases, and global infectious diseases and other global public health priorities.

Allows the Board of Trustees to authorize multiple nonprofit intermediaries to reward projects for interim research and development of products or for open source dividend prizes.

Requires the Comptroller General (GAO) to conduct annual audits to determine the Board's effectiveness in bringing to market new drugs, vaccines, biological products, and manufacturing processes in a cost-effective manner and in addressing society's global medical needs.

Establishes an annual fee for health insurers to fund this Act.

What's happening now March 20, 2013

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 627: Medical Innovation Prize Fund Act. 113th Congress. Open America. https://openamerica.io/bill/113-S-627/
MLA
"S. 627: Medical Innovation Prize Fund Act." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-S-627/.
Bluebook (legal)
S. 627, 113th Cong. (2026), https://openamerica.io/bill/113-S-627/.
Markdown link
[S. 627: Medical Innovation Prize Fund Act](https://openamerica.io/bill/113-S-627/)
Report a problem